NUR Stock Chart & Stats
€15.00
€0.40(2.65%)
At close: 4:00 PM EST
€15.00
€0.40(2.65%)
Day’s Range― - ―
52-Week Range€13.00 - €26.60
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
€221.03M
Enterprise Value€841.18M
Total Cash (Recent Filing)€83.70M
Total Debt (Recent Filing)€680.31M
Price to Earnings (P/E)―
Beta-0.02
Next Earnings
Aug 20, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.57
Shares Outstanding13,783,230
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio1.92
Price to Book (P/B)1.95
Price to Sales (P/S)8.11
P/FCF Ratio-2.94
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Renewable Asset OwnershipEllomay’s core model of owning and developing renewable power assets creates durable revenue potential from electricity generation. Ownership of assets supports long-term cash flows from sales, contracted tariffs or merchant markets and aligns with structural growth in renewable generation demand.
Multiple Monetization StreamsThe company can monetize projects via electricity sales, share-of-results from JV/associates, selling stakes after development, and residual equity cash flows post project debt. These diversified paths reduce reliance on a single revenue source and support medium-term value realization.
Underlying Operating MarginsRelatively strong EBITDA margins indicate core project economics and operational efficiency before non-cash depreciation and financing costs. This suggests assets can generate healthy operating cash once financing structures and non-operating costs are addressed over the medium term.
Bears Say
Very High LeverageDebt-to-equity around 5.1x materially constrains financial flexibility and raises refinancing, interest and covenant risks. High leverage makes the company vulnerable to cash flow shortfalls and increases the probability that asset sales or external financing will be needed to meet obligations over the medium term.
Persistently Negative Free Cash FlowConsistently deep negative free cash flow implies operations and investments do not cover cash needs, increasing dependency on external financing or asset disposals. Over months, this undermines balance sheet resilience and elevates execution risk for new developments and debt servicing.
Sharp Revenue Decline & LossesA ~45% TTM revenue decline with negative EBIT and substantial net losses signal weakening demand or asset underperformance. Sustained losses reduce retained earnings, impair reinvestment capacity and exacerbate leverage issues, making it harder to self-fund growth or withstand market shocks.
NUR FAQ
What was Ellomay Capital Ltd Ordinary Sh’s price range in the past 12 months?
Ellomay Capital Ltd Ordinary Sh lowest stock price was €13.00 and its highest was €26.60 in the past 12 months.
What is Ellomay Capital Ltd Ordinary Sh’s market cap?
Ellomay Capital Ltd Ordinary Sh’s market cap is €221.03M.
When is Ellomay Capital Ltd Ordinary Sh’s upcoming earnings report date?
Ellomay Capital Ltd Ordinary Sh’s upcoming earnings report date is Aug 20, 2026 which is in 40 days.
How were Ellomay Capital Ltd Ordinary Sh’s earnings last quarter?
Currently, no data Available
Is Ellomay Capital Ltd Ordinary Sh overvalued?
According to Wall Street analysts Ellomay Capital Ltd Ordinary Sh’s price is currently Overvalued.
Does Ellomay Capital Ltd Ordinary Sh pay dividends?
Ellomay Capital Ltd Ordinary Sh does not currently pay dividends.
What is Ellomay Capital Ltd Ordinary Sh’s EPS estimate?
Ellomay Capital Ltd Ordinary Sh’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Ellomay Capital Ltd Ordinary Sh have?
Ellomay Capital Ltd Ordinary Sh has 13,783,230 shares outstanding.
What happened to Ellomay Capital Ltd Ordinary Sh’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Ellomay Capital Ltd Ordinary Sh?
Currently, no hedge funds are holding shares in DE:NUR
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Ellomay Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
37.36%
12-Months-Change
Fundamentals
Return on Equity
-1.46%
Trailing 12-Months
Asset Growth
41.61%
Trailing 12-Months
Company Description
Ellomay Capital Ltd Ordinary Sh
Ellomay Capital Ltd. is an energy company operating across Israel, Spain, and the Netherlands, dedicated to producing renewable and clean power. Its assets include six operational photovoltaic (PV) plants: four located in Spain with a cumulative capacity of approximately 7.9 megawatts (MW), a significant 300 MW peak PV facility in Talaván, Spain, and one PV plant in Israel generating around 9 MW. The company also manages an 860 MWp dual-fuel power station situated near Ashkelon, Israel. Currently, Ellomay Capital is engaged in the construction of a 156 MW pumped storage hydroelectric power plant at Manara Cliff, Israel, and is also building another 28 MW PV plant in Talaván, Spain. Additionally, the company is developing anaerobic digestion facilities in the Netherlands, targeting green gas production of about 375 Nm3/h in Goor and approximately 475 Nm3/h in Oude-Tonge. Incorporated in 1987, the company, formerly known as NUR Macroprinters Ltd., adopted the name Ellomay Capital Ltd. in April 2008 and is headquartered in Tel Aviv-Yafo, Israel.
Technical Analysis
Options Prices
Currently, No data available
---